Search Results 571-580 of 24183 for In situ

  1. Vaccine Therapy and Resiquimod in Treating Patients with Stage II-IV Melanoma that has been Removed by Surgery - Mayo Clinic

    ... in-situ of the cervix; NOTE: If there is a history or prior malignancy, they must not be receiving other treatment for their cancer. Participating Mayo ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ, Male breast ...

  3. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

    Patients with of history of any other cancer (except nonmelanoma skin cancer or carcinoma in-situ of the cervix, unless in complete remission and off therapy ...

  4. Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52) - Mayo Clinic

    ... in situ cancer; Known active central nervous system (CNS) metastases and/or carcinomatous meningitis; Active autoimmune disease that has required systemic ...

  5. Lenalidomide and Low-Dose Dexamethasone in Patients with Previously Treated Multiple Myeloma and Kidney Dysfunction - Mayo Clinic

    Other active malignancy except for non melanoma skin cancer or in situ cervical or breast cancer. Concurrent radiation therapy, except for palliation of a ...

  6. Multiple endocrine neoplasia, type 2 (MEN 2) - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ, Fibroadenoma, ...

  7. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis - Mayo Clinic

    Patients with nonmelanoma skin cancer or carcinoma in situ of any type are not excluded if they have undergone complete resection. Participating Mayo Clinic ...

  8. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    HER2-negative defined as a negative in situ hybridization test or an immunohistochemistry (IHC) status of 0, 1+ or 2+. If IHC is 2+, a negative in situ ...

  9. Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer - Mayo Clinic

    Drugs used in chemotherapy, such as docetaxel and doxorubicin hydrochloride, work in ... EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix ...

  10. Oncology (Medical) - Clinical trials

    ... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...